Novel Interventions and Collaborations to Improving the Safe Use of Medications (U01)
The summary for the Novel Interventions and Collaborations to Improving the Safe Use of Medications (U01) Federal Grant is detailed below.
It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section.
If these sections are incomplete, please visit the website of the government agency that is offering this grant.
| Federal Grant Title: | NOVEL INTERVENTIONS AND COLLABORATIONS TO IMPROVING THE SAFE USE OF MEDICATIONS (U01) |
| Federal Agency Name: | Food and Drug Administration |
| Program Name: | Food and Drug Administration_Research |
| Grant Categories: | Agriculture Business and Commerce Community Development Education Employment Labor and Training Environment Food and Nutrition Health Information and Statistics Science and Technology |
| CFDA Number: | 93.103 |
| Funding Opportunity Number: | RFA-FD-11-024 |
| Posted Date: | Jun 17, 2011 |
| Creation Date: | Jun 22, 2011 |
| Original Application Deadline: | Jul 18, 2011 |
| Current Application Deadline: | Jul 18, 2011 |
| Archive Date: | Jul 19, 2011 |
| Total Program Funding: | $250,000 |
| Maximum Federal Grant Award: | $50,000 |
| Minimum Federal Grant Award: | Information not provided |
| Expected Number of Awards: | 5 |
| Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses
- Additional Information on Eligibility
- Information not provided
- Grant Description
- As part of FDA's Safe Use Initiative: Collaborating to Reduce Preventable Harm, FDA will identify drug/drug classes or therapeutic areas associated with preventable harm. The mission of the Safe use Initiative is to seek solutions to preventable harm associated with suboptimal use of regulated prescription and over the counter medications. The approach is to involve cross sector collaborations with other parts of healthcare committed to medication safety. This Funding Opportunity Announcement (FOA), issued by FDA, will provide resources for research to characterize preventable harm associated with specific FDA regulated drugs, identify sources (root causes) of the preventable harm and for the development and implementation of interventions to reduce the preventable harm.
- Link to Full Grant Announcement
-
http://grants.nih.gov/grants/guide/rfa-files/rfa-fd-11-024.html
- Grant Announcement Contact
- Stephanie Bogan Grants Management Specialist
stephanie.bogan@fda.hhs.gov [stephanie.bogan@fda.hhs.gov] - Similar Government Grants
- • Collaborating Centers of Excellence in Regulatory Science and Innovation (U01)
- • National Consumer Food Safety Education Conference (U13)
- • In vitro release tests for topical dermatological products (U01)
- • In vitro release tests for transdermal drug delivery systems (U01)
- • Systematic Evaluation of Excipient Effects on the Efficacy of Metered Dose Inhaler Product...
- • Support for Small Scientific Conference Grant Program
- • Cooperative Agreement to Support the World Health Organization (WHO) International Program...
- • Clinical Studies of Safety and Effectiveness of Orphan Products
- More Grants from the Food and Drug Administration
- • Collaborating Centers of Excellence in Regulatory Science and Innovation (U01)
- • National Consumer Food Safety Education Conference (U13)
- • In vitro release tests for topical dermatological products (U01)